Cannabinoid · Synthetic (research chemical)
AM-2201 is a fully synthetic naphthoylindole cannabinoid and second-generation Spice agonist with high harm risk, part of a class linked to serious harm and deaths.
Where it fits
AM-2201 derives from Synthetic. See the Synthetic & altered cannabinoids index for how it relates to the rest of the family.
What the research shows
Direct human research on AM-2201 is minimal; it is characterised mainly by its chemistry and its place in the cannabinoid family rather than by clinical studies. We flag that plainly rather than overstate it.
Safety
A fully synthetic cannabinoid, covered for education and harm reduction only. Synthetic cannabinoids are potent, unpredictable and linked to serious harm and deaths. No synthesis, dose or source information appears on this site.
Frequently Asked Questions
What is AM-2201 and how does it differ from natural THC?
AM-2201 is a fluorinated naphthoylindole synthetic cannabinoid (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) that acts as a high-affinity full agonist at CB1 and CB2 receptors, whereas plant-derived delta-9-THC is a partial agonist.
Does AM-2201 occur naturally in cannabis flower?
No. AM-2201 is a purely laboratory-synthesized chemical compound originally developed as a research ligand and later detected in illicit smoking mixtures.
Why are fluorinated synthetic cannabinoids like AM-2201 hazardous?
Full CB1 receptor agonism combined with rapid formation of active hydroxylated and defluorinated metabolites (including JWH-018 pentanoic acid metabolites) is linked to acute psychosis, convulsions, cardiotoxicity, and emergency hospitalizations.
Sources
- Chimalakonda, K. C., Seely, K. A., Bratton, S. M., Brents, L. K., Moran, C. L., Endres, G. W., James, L. P., Hollenberg, P. F., Prather, P. L., Radominska-Pandya, A., & Moran, J. H. (2012). Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. Drug Metabolism and Disposition, 40(11), 2174-2184. PubMed 22904561
- Banister, S. D., Stuart, J., Kevin, R. C., Edington, A., Longworth, M., Wilkinson, S. M., Beinat, C., Buchanan, A. S., Hibbs, D. E., Glass, M., Connor, M., McGregor, I. S., & Kassiou, M. (2015). Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chemical Neuroscience, 6(8), 1445-1458. PubMed 25923234
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA / EUDA). Synthetic cannabinoids in Europe: a review. EUDA / EMCDDA Profile
- National Center for Biotechnology Information (NCBI). PubChem Compound Summary for CID 44397290, AM-2201. NCBI PubChem CID 44397290
Part of the NOIDS cannabinoids index. Educational reference, not medical advice.